Tuesday, June 2, 2020
wellness India Expo
Home Tags SII

Tag: SII

Serum Institute seeks fast-track regulatory clearances for the COVID-19 vaccine

In a bid to generate a vaccine candidate at the earliest, the Serum Institute of India-Codagenix developed novel coronavirus virus-vaccine strain is pegged as the first in its form to progress to the pre-clinical trial phase.......................

Serum Institute develops novel coronavirus vaccine candidate, human trials in 6...

Serum Institute of India-Codagenix developed novel coronavirus virus-vaccine strain is first to progress to pre-clinical testing phase. The project has been running at an estimated cost of INR 300 crores......................

Celebrating India’s role as the vaccine hub of the world

The Serum Institute, PATH, WHO and Bill & Melinda Gates Foundation with support from the Department of Biotechnology celebrated the clinical development, manufacturing and scale-up of MenAfriVac vaccine......

Serum Institute, Cipla launch Hepatitis B vaccine in India

Under a co-exclusive agreement with Serum Institute of India (SII), global pharmaceutical company Cipla has launched adult Hepatitis B vaccine in India.....